BackOsmotica Pharmaceuticals Plc Overview

Osmotica Pharmaceuticals Plc Other Current Liabilities

Track Osmotica Pharmaceuticals Plc's other current liabilities ($6.9M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$6.86M
37.83% YoYΔ $-4.17M vs prior year quarter

Peer average

Loading

Osmotica Pharmaceuticals Plc Other Current Liabilities History

Loading

Osmotica Pharmaceuticals Plc vs. peers: Other Current Liabilities Comparison

Loading

Osmotica Pharmaceuticals Plc Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Osmotica Pharmaceuticals Plc (OSMT) FAQ

Osmotica Pharmaceuticals Plc (OSMT) currently reports a other current liabilities of $6.9M as of June 2023. That compares with $11M in the prior-year period — down 37.8% year over year. Use the charts on this page to explore Osmotica Pharmaceuticals Plc's other current liabilities history and peer comparisons.

Osmotica Pharmaceuticals Plc's other current liabilities decreased from $11M to $6.9M — a 37.8% year-over-year decrease (period ending June 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Osmotica Pharmaceuticals Plc reported $6.9M in other current liabilities as of June 2023. That compares with $11M in the prior-year period — down 37.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $6.9M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Osmotica Pharmaceuticals Plc, and consider following OSMT for alerts when major investors trade the stock.

Osmotica Pharmaceuticals Plc is classified in the Healthcare sector. On other current liabilities, it currently shows $6.9M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing OSMT with unrelated industries.